about
Biotechnological applications of functional metagenomics in the food and pharmaceutical industriesComparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.Antimicrobial Stewardship Initiatives Throughout Europe: Proven Value for MoneySingle cell antimicrobial susceptibility testing by confined microchannels and electrokinetic loading.Inhibition of class A and C beta-lactamases by diaroyl phosphates.Burden of carbapenem-resistant organisms in the Frankfurt/Main Metropolitan Area in Germany 2012/2013 - first results and experiences after the introduction of legally mandated reporting.Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan.Septic shock and adequacy of early empiric antibiotics in the emergency department.Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities.Antimicrobial efficacy of two surface barrier discharges with air plasma against in vitro biofilms.Interaction of silver nanoparticles with Escherichia coli and their cell envelope biomolecules.Marine-derived quorum-sensing inhibitory activities enhance the antibacterial efficacy of tobramycin against Pseudomonas aeruginosaIdentification of novel antimicrobial resistance genes from microbiota on retail spinach.Use of 16S rRNA gene for identification of a broad range of clinically relevant bacterial pathogens.Functional genomics to identify the factors contributing to successful persistence and global spread of an antibiotic resistance plasmid.Antibiofilm Activity of the Brown Alga Halidrys siliquosa against Clinically Relevant Human PathogensReplication and Active Partition of Integrative and Conjugative Elements (ICEs) of the SXT/R391 Family: The Line between ICEs and Conjugative Plasmids Is Getting Thinner.The class A β-lactamase FTU-1 is native to Francisella tularensis.Origin and evolution of antibiotic resistance: the common mechanisms of emergence and spread in water bodies.Environmental dissemination of antibiotic resistance genes and correlation to anthropogenic contamination with antibiotics.Detection of Rare Antimicrobial Resistance Profiles by Active and Passive Surveillance Approaches.Experimental and In-Silico Investigation of Anti-Microbial Activity of 1-Chloro-2-Isocyanatoethane Derivatives of Thiomorpholine, Piperazine and Morpholine.Evaluation of Ceftriaxone utilization in internal medicine wards of general hospitals in Addis Ababa, Ethiopia: a comparative retrospective study.Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-AnalysisCharacteristics of antimicrobial studies registered in the USA through ClinicalTrials.GovCarriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey.Structure-activity relations of myxinidin, an antibacterial peptide derived from the epidermal mucus of hagfishAntimicrobial peptide GL13K is effective in reducing biofilms of Pseudomonas aeruginosa.A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.Antimicrobial peptides: promising alternatives to conventional antibiotics.Association between antimicrobial resistance and virulence in Escherichia coli.Selection of antibiotics for meticillin-resistant Staphylococcus pseudintermedius: time to revisit some old drugs?Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.Towards an integrated model of bacterial conjugation.Urinary tract infections due to ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis.Distribution of antibiotic resistance genes in glacier environments.Role of house flies in the ecology of Enterococcus faecalis from wastewater treatment facilities.Preventive antibiotics in stroke study: rationale and protocol for a randomised trial.Antibiotic prescribing in dental practice in Belgium.[Mandatory reporting of antimicrobial-resistant pathogens. What should, what can be achieved? : assessment related to the particular facility seems crucial].
P2860
Q26801646-0B0F6DD1-4484-4989-9103-5CDB14544041Q33542819-0FF03004-34E2-4AF0-BD70-2AF0BE852724Q33564287-8ED6CBD2-3755-423E-848D-D13A2F5BA938Q33915975-EB45FC00-76DE-4EAC-ACEC-91A5E034BF3CQ33958491-8016BA91-4B01-4C16-AA25-8FF8F46F2A09Q34084965-4508948D-E656-4A70-8214-53976394C999Q34332967-DF4B7FE0-40A1-47CB-8B4C-2DD876CEC57BQ34622562-12724C57-A0BD-4695-9C76-13A9EB0D96E3Q34623275-8EB93441-0EC4-43E2-81EF-13F0490B5A22Q34876483-194F3F5F-994F-4D40-B0CA-CDCE44D0B617Q34985489-3C127A3D-43E7-4D54-B5DB-F2FB2D6D03E0Q35015292-6893EAE5-C296-44B3-BEF3-5BFB83B3BB82Q35056651-1BCA410D-438D-4F0B-89A5-AC2CFEA4C8DCQ35058071-B91EB997-2DFF-4B17-9FC1-95783AD27168Q35194205-D5123309-1094-4630-86D4-7D640517702EQ35658468-735591E7-BC0E-44D2-8DA1-B211CFBE92D7Q35659811-0BCC70F0-5330-4334-8D26-8D4ECF52EEC0Q35689231-DEF80C84-2E67-49B8-8C46-F96F42E63504Q35698156-758295FF-FAFE-4F2F-8EA1-F3A0770C1CA9Q36045610-1604E34C-5336-40BB-AECF-9BAF4BB17AF0Q36071671-E06A02DA-E5DE-48EE-B1C8-C13EB3D81AD1Q36255429-A2E643E7-2026-44F6-845E-F504009B5CF1Q36263262-A59F7A7C-842A-4193-9615-5A8BFC3272B7Q36265042-3A4742B3-9C22-415F-B05E-29195C254A69Q37022012-80C81AC5-FDF7-4E57-978A-F074A6F547CDQ37156538-C3A1172C-7040-451E-A6C1-59C24204AB67Q37263518-DB702C97-6C14-4863-A4BB-6AB1789B47E8Q37263735-6F182087-65D3-48BD-B4D6-6F3CA03552C1Q37287708-3C2159CC-4FF5-4DA4-8BEB-57D448BE12ECQ37926863-32D20ACB-85B1-43B5-8304-639E416E46E3Q37979685-FC2B88EA-14ED-4843-B325-96A14438582EQ37982099-3451323D-3C1E-4759-9742-327F37CEEB40Q38241417-64B4A339-51F4-4475-95E3-30ABC403AC53Q38242996-39802DFB-FC3F-44FE-A6BF-5A42A59D3F6EQ38627263-DA5B82AD-6B89-4C94-83F9-A12A4BD6464DQ39123040-DA270B01-1095-47E1-9E7A-314C8AD0F5C3Q40157718-7BB436D9-1ACE-4C86-949A-0A20FD519F47Q40332122-434E4A85-51C9-4C59-9673-7504ABC7942DQ40374156-5EFA95DF-960F-4752-AD7F-E221E1844E42Q41697861-19882416-F903-4128-AC89-39678D3BE1C0
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The growing burden of antimicrobial resistance.
@ast
The growing burden of antimicrobial resistance.
@en
type
label
The growing burden of antimicrobial resistance.
@ast
The growing burden of antimicrobial resistance.
@en
prefLabel
The growing burden of antimicrobial resistance.
@ast
The growing burden of antimicrobial resistance.
@en
P2860
P356
P1476
The growing burden of antimicrobial resistance.
@en
P2093
P M Hawkey
P2860
P356
10.1093/JAC/DKN241
P407
P478
62 Suppl 1
P577
2008-09-01T00:00:00Z